On February 22, Janssen China signed a Memorandum of Understanding on Strategic Cooperation (the "Memorandum") with the National Center for Infectious Disease Medicine (relying on Huashan Hospital affiliated to Fudan University, hereinafter referred to as the "National Center") and the Shanghai Huashen Institute of Microbiology and Infection. All parties will carry out strategic cooperation in the dimensions of scientific research, technology development, industrial transformation and academic exchanges, aiming to promote the sustainable development of the field of anti-infection, improve the level of public health, and help build a "Healthy China 2030".
Signing ceremony of memorandum of understanding on strategic cooperation
The 14th Five-Year Plan clearly points out that the focus of adjusting the medical and health system will shift to the field of public health. As one of the core disease areas of public health, the prevention and treatment of infectious diseases is of great significance to improving the level of public health in China. Professor Zhang Wenhong, director of the National Center, said, "At present, the diagnosis, treatment and prevention of infectious diseases in the mainland are still facing severe challenges, and the signing of this memorandum will deepen the in-depth cooperation between the National Center and Janssen, and the results of the cooperation will help improve the diagnosis level of clinicians, improve the accessibility of innovative treatment protocols and drugs, and bring about sustained and effective patient management." ”
Professor Zhang Wenhong, Director of the National Center for Infectious Diseases
Zheng Lei, President of Janssen China, said: "As a transformative and innovative medical enterprise and one of the earliest multinational pharmaceutical companies to deeply cultivate In China, Janssen China has always actively promoted the deep integration and innovation of industrial ecology to promote the development of the public health field. The signing of this Memorandum of Understanding will focus on patient-centered integrated solutions for diagnosis and treatment, and create a win-win anti-infection ecosystem, which is another important commitment for us to help China's public health cause. ”
Ms. Zheng Lei, President of Janssen China
According to the memorandum, Janssen China and the National Center will link up multiple partners to build a patient-centered diagnosis and treatment integration platform for the whole path of disease discovery, diagnosis and treatment, and create a win-win anti-infection ecosystem to achieve a new pattern of infection prevention and treatment. Taking MDR-TB as an example, the patient-centered ecosystem will build a full-cycle management of MDR-TB screening, identification, referral, treatment and follow-up by integrating government agencies and multi-industry partners, and build a standardized treatment system and referral mechanism for MDR-TB, so as to bring greater benefits to patients.
The construction of the anti-infection ecosystem can not only help patients achieve early diagnosis and early treatment, obtain more optimized disease management, but also improve the diagnosis and treatment level of grass-roots medical staff, help the comprehensive development of anti-infection disciplines, and increase the opportunity for dialogue between all parties in the industry, promote diversified exchanges and cooperation in the field of anti-infection, and promote the deep integration and innovation of the industrial ecology.
[Reporter] Ou Xujiang
【Author】 Ou Xujiang
Healthy living circle